JNJ Stock Overview – The Average Joe

Newsletter

Latest Issues Subscribe

Company

About Us Jobs
×

Become a better investor with our free daily newsletters

Join 250,000+ investors discovering new market trends and ideas.

NYSE:JNJ

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

July 18, 2024

Description

Loading...

Price Performance

1M 6M 1Y 5Y 10Y
$JNJ N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A

Valuation

P/E Ratio (TTM) P/S Ratio (TTM)
Johnson & Johnson Loading... Loading...
Sector Name Loading... N/A

Related

MRKMerck & Co., Inc.-2.6%
BMYBristol-Myers Squibb Company-0.9%
AMGNAmgen Inc.-1.9%
PFEPfizer Inc.-2.0%
ABBVAbbVie Inc.-1.3%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2014FY 2016FY 2017FY 2017FY 2018FY 2019FY 2021FY 2022FY 2023FY 2023
Revenue74,331M70,074M71,890M76,450M81,581M82,059M82,584M93,775M94,943M85,152M
Growth Rate--5.7%2.6%6.3%6.7%0.6%0.6%13.6%1.2%-10.3%
EBITDA21,315M19,022M21,685M19,839M22,552M22,126M20,342M25,699M24,024M29,339M
EBITDA Margin28.7%27.1%30.2%26.0%27.6%27.0%24.6%27.4%25.3%34.5%
Net Income16,323M15,409M16,540M1,300M15,297M15,119M14,714M20,878M17,941M35,153M
NI Margin22.0%22.0%23.0%1.7%18.8%18.4%17.8%22.3%18.9%41.3%